- Home
- VYGR vs ANNA Comparison
VYGR vs ANNA Comparison
Compare VYGR & ANNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- ANNA
- Stock Information
- Founded
- VYGR 2013
- ANNA 2007
- Country
- VYGR United States
- ANNA United States
- Employees
- VYGR N/A
- ANNA N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- ANNA
- Sector
- VYGR Health Care
- ANNA
- Exchange
- VYGR Nasdaq
- ANNA NYSE
- Market Cap
- VYGR 222.9M
- ANNA 230.0M
- IPO Year
- VYGR 2015
- ANNA N/A
- Fundamental
- Price
- VYGR $3.41
- ANNA $7.40
- Analyst Decision
- VYGR Strong Buy
- ANNA
- Analyst Count
- VYGR 9
- ANNA 0
- Target Price
- VYGR $14.86
- ANNA N/A
- AVG Volume (30 Days)
- VYGR 360.5K
- ANNA 19.0K
- Earning Date
- VYGR 03-11-2025
- ANNA 05-15-2025
- Dividend Yield
- VYGR N/A
- ANNA N/A
- EPS Growth
- VYGR N/A
- ANNA N/A
- EPS
- VYGR N/A
- ANNA N/A
- Revenue
- VYGR $80,001,000.00
- ANNA $648,328.00
- Revenue This Year
- VYGR N/A
- ANNA N/A
- Revenue Next Year
- VYGR $23.46
- ANNA N/A
- P/E Ratio
- VYGR N/A
- ANNA N/A
- Revenue Growth
- VYGR N/A
- ANNA N/A
- 52 Week Low
- VYGR $3.56
- ANNA $4.71
- 52 Week High
- VYGR $10.66
- ANNA $18.70
- Technical
- Relative Strength Index (RSI)
- VYGR 28.74
- ANNA N/A
- Support Level
- VYGR $3.58
- ANNA N/A
- Resistance Level
- VYGR $3.96
- ANNA N/A
- Average True Range (ATR)
- VYGR 0.25
- ANNA 0.00
- MACD
- VYGR -0.01
- ANNA 0.00
- Stochastic Oscillator
- VYGR 2.60
- ANNA 0.00
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About ANNA ALEANNA INC
AleAnna Inc is a developer and producer of natural gas in Italy, engaged in naturally occurring biogenic methane from conventional geological formations and carbon-negative renewable biomethane generated from farm wastes, particularly in the Po Valley of Northern Italy.